BMK-32355-31458
5 vaccinations
8 coded responses
23 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Registered in v-safe
-
2021-01-29
Health check-in — day 7, dose 1Feeling: Good · Site: Pain · Chills, Headache, Muscle or body achesAdult check-in
- 2021-02-05
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-19
Survey response — day 7, dose 2MedDRA: Dizziness — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-06
- 2021-03-21
- 2021-03-31
-
2021-08-15
Survey response — 6 months, dose 2MedDRA: Fatigue, Headache, Nasal congestion — Feeling: FairFree text: Headache, nasal congestion, fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-16
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 42, dose 3MedDRA: Fatigue, Pericardial effusion, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Mild pericardial effusion. More fatigue. · Healthcare visit (other): Scheduled echoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-06
- 2021-11-17
-
2022-03-21
Dose 4 — Pfizer-BioNTech
-
2022-04-14
Survey response — day 21, dose 4MedDRA: Office visit, Pre-existing disease, Psoriasis, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Sinus infection and Psoriasis flare · Healthcare visit (other): Office visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-19
-
2022-04-27
Survey response — day 35, dose 4MedDRA: Cough, Fatigue, Headache, Pre-existing disease, Psoriasis, Respiratory tract congestion — Feeling: PoorFree text: Headache, congestion, fatigue, cough, psoriasis flare.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Dose 5 — Pfizer-BioNTech
-
2022-10-13
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-14
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-10-15
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Health check-in — day 7, dose 5Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-11-11
Survey response — day 28, dose 5MedDRA: Polyp, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infection and polypMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — day 28, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-14
- 2022-11-14
- 2022-11-14
- 2022-11-23
-
2023-04-14
Survey response — 6 months, dose 5MedDRA: Gastrointestinal disorder, Sinus operation, Sinusitis, Tachycardia, Uterine dilation and curettage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-14
Report sent to call center — 6 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-04-17
- 2023-04-17
- 2023-04-17
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech | |
| 3 | 2021-08-16 | Pfizer-BioNTech | No |
| 4 | 2022-03-21 | Pfizer-BioNTech | No |
| 5 | 2022-10-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-01 | Unsuccessful | |
| 2022-04-14 | Unsuccessful | |
| 2022-11-11 | Unsuccessful | |
| 2023-04-14 | Unsuccessful |
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Dizziness
Release 9 — 6 months, dose 2
Symptoms: Headache, nasal congestion, fatigue
Release 9 — day 42, dose 3
Symptoms: Mild pericardial effusion. More fatigue.
Healthcare visit (other): Scheduled echo
Release 11 — day 21, dose 4
Release 11 — day 35, dose 4
Symptoms: Headache, congestion, fatigue, cough, psoriasis flare.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Swollen lymph node
Release 12 — day 28, dose 5
Symptoms: Sinus infection and polyp
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Nasal congestion | ✓ | · | ✓ |
| SD | Pericardial effusion | · | · | ✓ |
| SD | Polyp | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Psoriasis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus operation | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release